Aktienanalyse zu Harvard Ave Acquisition Corp (HAVA)

KI-Analyse of Harvard Ave Acquisition Corp (HAVA)

Halten

Currently, HAVA is not a strong buy. The stock is trading at $10.27, which is close to its 52-week high of $10.32, indicating limited upside potential. The RSI is at 51.39, suggesting the stock is neither overbought nor oversold. While the company has shown a positive trend in net income with a significant increase to $1,135,236 in Q1 2026, the forward P/E ratio is 0, indicating uncertainty in future earnings. The main risk is the high price-to-book ratio of 2279.89, which suggests that the stock may be overvalued relative to its book value.

Bewertungskennzahlen

Das aktuelle erwartete KGV von Harvard Ave Acquisition Corp (HAVA) beträgt 0.00, verglichen mit dem 5-Jahres-Durchschnitt von 0.00.

Erwartetes KGV

Stark unterbewertet

5J-Durchschnitt P/E

0.00

Aktuelles P/E

0.00

Überbewertet

0.00

Unterbewertet

0.00

Erwartetes EV/EBITDA

Stark unterbewertet

5J-Durchschnitt EV/EBITDA

0.00

Aktuelles EV/EBITDA

0.00

Überbewertet

0.00

Unterbewertet

0.00

Erwartetes KUV

Stark unterbewertet

5J-Durchschnitt P/S

0.00

Aktuelles P/S

0.00

Überbewertet

0.00

Unterbewertet

0.00

Whales, die HAVA halten

W

Whitebox Advisors LLC

+ HältHAVA

-8.02%

3-Monats-Rendite

HAVA FAQ – beantwortet von Alphio AI

Harvard Ave Acquisition Corp is a company formed for the sole purpose of merging with existing corporations. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company does not intend to limit its search for a target business to any particular industry or geographic location. It operates in the Financials sector.

Currently, HAVA is not a strong buy. The stock is trading at $10.27, which is close to its 52-week high of $10.32, indicating limited upside potential. The RSI is at 51.39, suggesting the stock is neither overbought nor oversold. While the company has shown a positive trend in net income with a significant increase to $1,135,236 in Q1 2026, the forward P/E ratio is 0, indicating uncertainty in future earnings. The main risk is the high price-to-book ratio of 2279.89, which suggests that the stock may be overvalued relative to its book value.